Akèy › Vil › Pennsylvania › Spring House
Pwonse H-1B nan Spring House, PA
Anplwayè yo te depoze 78 aplikasyon kondisyon travay pou travay nan Spring House, PA pandan ane fiskal 2023–2026. Salè baz medyàn ofri: $140,020.
Demann (LCA)78
Salè medyan ofri$140,020
Mwatye salè yo$104,375–$161,275
10yèm–90yèm pousantaj$61,200–$191,920
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Pi gwo pwonse yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Janssen Research & Development, LLC | 59 | $152,850 |
| Eurofins Lancaster Laboratories Professional Scientific Services, LLC | 7 | $57,678 |
| Eurofins Professional Scientific Services Mid-Atlantic, LLC. | 4 | $51,356 |
| Cognizant Technology Solutions US Corp | 2 | $136,250 |
| Johnson & Johnson Services, Inc. | 1 | $152,000 |
| Medical Device Business Services, Inc. | 1 | $115,000 |
| Eight Eleven Group, LLC | 1 | $135,200 |
| Catalyst Group LLC | 1 | $105,000 |
| Infobahn Softworld Inc. | 1 | $60,000 |
| Amzur Technologies, Inc | 1 | $99,819 |
Oksipasyon
| Metiyè | LCA | Salè medyan |
|---|---|---|
| Medical Scientists, Except Epidemiologists | 18 | $162,322 |
| Biochemists and Biophysicists | 14 | $130,104 |
| Molecular and Cellular Biologists | 13 | $106,088 |
| Biological Technicians | 9 | $54,798 |
| Statisticians | 6 | $153,300 |
| Data Scientists | 5 | $115,000 |
| Computer Systems Engineers/Architects | 3 | $142,771 |
| Microbiologists | 3 | $114,200 |
| Bioengineers and Biomedical Engineers | 1 | $175,000 |
| Natural Sciences Managers | 1 | $160,300 |
| General and Operations Managers | 1 | $282,600 |
| Software Developers | 1 | — |
| Electrical Engineers | 1 | $110,000 |
| Operations Research Analysts | 1 | $105,000 |
| Mechatronics Engineers | 1 | $99,819 |
Tit travay
- Senior Scientist4
- Principal Scientist4
- Scientist III3
- Scientist II Analytical3
- Associate Scientist II Multispecifics2
- Senior Scientist, Clinical Pharmacology2
- Sr. Mgr. JC45 - Information Technology Project Managers2
- Data Analyst/Laboratory Operations Specialist2
- Analyst, Functional Planning (PSTS)2
- Associate Director, Cell Therapy Process Development1
- Post-doctoral Fellow Oncology1
- Scientist, Cell & Gene Therapy Process Development1
- Senior Manager Oncology CDx /TR Biomaker Operations1
- Manager, Risk Management - Central Monitoring1
- IT Manager - LIMS application1
- Senior Statistician1
- Supply Chain Data Engineer1
- Cell and Gene Therapy and Vaccines Scientist Group Leader1
- Senior Scientist Clinical Pharmacology and Pharmacometrics1
- Statistical Programming Lead1
- Senior Scientist I1
- Cell Therapy Scientist1
- Scientist Oligonucleotide BT1
- Director, Business Operations & Excellence1
- Sr. Scientist, Colon Organoid Specialist1
- Senior Scientist QSP1
- Principal Scientist QSP1
- Experienced Scientist Oncology TR - Cell Therapy1
- Associate Director, Clinical Pharmacology1
- Associate Scientist II1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).